EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcomes of HPV + Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery

Theodore A Gobillot, Gregory Weinstein, Austin Cao iD, Jake J Lee, Robert M Brody iD, Devraj Basu, Bert W O'Malley, D Gregory Farwell, Steven Cannady, Alexander Lin, John Lukens, Michelle Gentile und 7 weitere

The Laryngoscope · 2025-12 · 135 (12) · 4707-4715

DOI: 10.1002/lary.32449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 13.08.2025. Verfasst von Theodore A Gobillot und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Treatment of patients with head and neck squamous cell carcinoma of unknown primary (CUP) is challenging. Given the relative rarity of this condition and the recent use of primary transoral robotic surgery (TORS) in modern diagnostic and treatment algorithms, long‐term oncologic outcomes are unclear. The objectives were to evaluate oncologic outcomes of patients treated with TORS for management of CUP.

Methods

This retrospective case series was conducted at a tertiary care academic medical center from 2010 to 2021. All patients with HPV‐mediated CUP who underwent TORS‐assisted endoscopy were included. CUP was defined as biopsy‐proven squamous cell carcinoma in a cervical lymph node with uncertain primary location following standard‐of‐care clinical and radiologic assessment. Primary outcomes were recurrence‐free survival and overall survival. Secondary outcomes included usage of radiation and chemotherapy.

Results

In total, 157 patients were included in the study. Median follow‐up time was 62 months. Primary tumor was identified in 88% of patients. Surgery alone was performed in 21%, although adjuvant therapy was recommended but declined in 13%. Adjuvant radiation was completed in 46% and adjuvant chemoradiation in 33%. Two‐thirds of patients avoided chemoradiation. Overall survival was 94% and recurrence‐free survival was 92% at 5 years.

Conclusion

In the largest reported experience to date of TORS‐assisted management of CUP, we demonstrate that this approach facilitates a high rate of identification of occult mucosal malignancies and can eliminate the need for chemotherapy and potentially radiation therapy in select patients without compromising excellent oncologic and functional outcomes. Level of Evidence: 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresNeoplasms, Unknown PrimaryOropharyngeal NeoplasmsPapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckNatural Orifice Endoscopic SurgeryHumansMaleRetrospective StudiesFemaleMiddle AgedAgedTreatment OutcomeAdult

Stichwörter der Autor:innen

human papilloma virusoropharynxtransoral robotic surgeryunknown primary

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology, University of Maryland, Baltimore, Maryland, USA.
  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Austin Cao, Robert M Brody, Karthik Rajasekaran

Zitieren

APA

Gobillot, T. A., Weinstein, G., Cao, A., Lee, J. J., Brody, R. M., Basu, D., O'Malley, B. W., Farwell, D. G., Cannady, S., Lin, A., Lukens, J., Gentile, M., Newman, J. G., Chalian, A. A., Sun, L., Lakshmipathy, D., Cohen, R. B., Rasskeh, C. H., & Rajasekaran, K. (2025). Outcomes of HPV + Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery. The Laryngoscope, 135(12), 4707-4715. https://doi.org/10.1002/lary.32449

Vancouver

Gobillot TA, Weinstein G, Cao A, Lee JJ, Brody RM, Basu D, et al. Outcomes of HPV + Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery. The Laryngoscope. 2025;135(12):4707-4715. doi:10.1002/lary.32449

BibTeX
@article{Gobillot2025,
  author = {Gobillot, Theodore A and Weinstein, Gregory and Cao, Austin and Lee, Jake J and Brody, Robert M and Basu, Devraj and O'Malley, Bert W and Farwell, D Gregory and Cannady, Steven and Lin, Alexander and Lukens, John and Gentile, Michelle and Newman, Jason G and Chalian, Ara A and Sun, Lova and Lakshmipathy, Deepak and Cohen, Roger B and Rasskeh, Christopher H and Rajasekaran, Karthik},
  title = {Outcomes of HPV + Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery},
  journal = {The Laryngoscope},
  year = {2025},
  volume = {135},
  number = {12},
  pages = {4707--4715},
  doi = {10.1002/lary.32449}
}
Kostenlos starten →